
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0348 | -12.4910265614 | 0.2786 | 0.285 | 0.2377 | 253866 | 0.26421865 | CS |
4 | -0.0356 | -12.7415891195 | 0.2794 | 0.2884 | 0.2377 | 256359 | 0.26376799 | CS |
12 | -0.0052 | -2.08835341365 | 0.249 | 0.37 | 0.2355 | 1408393 | 0.32572468 | CS |
26 | 0.0733 | 42.991202346 | 0.1705 | 0.63 | 0.1406 | 10906899 | 0.46705124 | CS |
52 | -2.6662 | -91.6219931271 | 2.91 | 3.18 | 0.1406 | 6719629 | 0.45523437 | CS |
156 | -1.0062 | -80.496 | 1.25 | 4.16 | 0.1406 | 2489499 | 0.62705156 | CS |
260 | -2.0762 | -89.4913793103 | 2.32 | 5.75 | 0.1406 | 1709768 | 0.92918822 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales